Thrombin mutant W215A/E217A treatment improves neurological outcome and attenuates central nervous system damage in experimental autoimmune encephalomyelitis.
Verbout NG, Yu X, Healy LD, Phillips KG, Tucker EI, Gruber A, McCarty O J, Offner H
Metab Brain Dis. 2014 May 9. PMID: 24810631.Abstract